
    
      This study is a multi-center research on economic burdens of COPD for a year. It is composed
      of three phases detailed as follow.

      Phase 1: Direct Cost Estimation in COPD patients (N = 400) Direct cost determined as amount
      of money expended to medical institutes for treatment. Estimated costs, based on the
      information from Health insurance review agency(HIRA) and The National Health and Nutrition
      Examination Survey (NHANES) data, are collected.

      Phase 2: Indirect cost Estimation by Sampling Survey in COPD patient Indirect cost is
      extra-expanses excluding hospital fees, including cost for transportation, medical
      instruments, home care services and loss of labor capacity reduction. The information was
      collected by structured questionnaire for 12 weeks.

      Phase 3: Direct/Indirect cost is validated and analyzed based on the collected information
      from phase 1 and 2 according to severity defined by the GOLD guideline.
    
  